Literature DB >> 17590456

Conduction disorder and QT prolongation secondary to long-term treatment with chloroquine.

Philippe Stas, Dirk Faes, Patrick Noyens.   

Abstract

A patient with polymorphic ventricular tachycardia, long QT interval and conduction disorders secondary to long-term treatment with chloroquine is presented.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17590456     DOI： 10.1016/j.ijcard.2007.04.055

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN： 0167-5273            Impact factor:   4.164


  20 in total

1.  Cardiac Complications Attributed to Chloroquine and Hydroxychloroquine: A Systematic Review of the Literature.

Authors:  Clotilde Chatre; François Roubille; Hélène Vernhet; Christian Jorgensen; Yves-Marie Pers
Journal:  Drug Saf       Date:  2018-10       Impact factor: 5.606

Review 2.  Therapeutic use of chloroquine and hydroxychloroquine in COVID-19 and other viral infections: A narrative review.

Authors:  Anwar M Hashem; Badrah S Alghamdi; Abdullah A Algaissi; Fahad S Alshehri; Abdullah Bukhari; Mohamed A Alfaleh; Ziad A Memish
Journal:  Travel Med Infect Dis       Date:  2020-05-06       Impact factor: 6.211

3.  Inpatient use of mobile continuous telemetry for COVID-19 patients treated with hydroxychloroquine and azithromycin.

Authors:  James Gabriels; Moussa Saleh; David Chang; Laurence M Epstein
Journal:  HeartRhythm Case Rep       Date:  2020-04-01

Review 4.  Cardiovascular Safety of Potential Drugs for the Treatment of Coronavirus Disease 2019.

Authors:  Gaurav Aggarwal; Brandon Michael Henry; Saurabh Aggarwal; Sripal Bangalore
Journal:  Am J Cardiol       Date:  2020-05-16       Impact factor: 2.778

Review 5.  A Bitter Taste in Your Heart.

Authors:  Conor J Bloxham; Simon R Foster; Walter G Thomas
Journal:  Front Physiol       Date:  2020-05-08       Impact factor: 4.566

6.  Hydroxychloroquine Use Is Not Associated With QTc Length in a Large Cohort of SLE and RA Patients.

Authors:  Elizabeth Park; Jon T Giles; Thania Perez-Recio; Paloma Pina; Christopher Depender; Yevgeniya Gartshteyn; Anca Askanase; Joan Bathon; Laura Geraldino-Pardilla
Journal:  Res Sq       Date:  2021-06-29

Review 7.  SARS-CoV-2: Origin, Evolution, and Targeting Inhibition.

Authors:  Shuo Ning; Beiming Yu; Yanfeng Wang; Feng Wang
Journal:  Front Cell Infect Microbiol       Date:  2021-06-17       Impact factor: 5.293

Review 8.  Long QT Syndrome: An Emerging Role for Inflammation and Immunity.

Authors:  Pietro Enea Lazzerini; Pier Leopoldo Capecchi; Franco Laghi-Pasini
Journal:  Front Cardiovasc Med       Date:  2015-05-27

9.  QT prolongation in a diverse, urban population of COVID-19 patients treated with hydroxychloroquine, chloroquine, or azithromycin.

Authors:  Brian C Hsia; Nicolas Greige; Jose A Quiroz; Ahmed S Khokhar; Johanna Daily; Luigi Di Biase; Kevin J Ferrick; John D Fisher; Andrew Krumerman
Journal:  J Interv Card Electrophysiol       Date:  2020-07-11       Impact factor: 1.900

10.  The Antimalarial Chloroquine Reduces the Burden of Persistent Atrial Fibrillation.

Authors:  Catalina Tobón; Laura C Palacio; Bojjibabu Chidipi; Diana P Slough; Thanh Tran; Nhi Tran; Michelle Reiser; Yu-Shan Lin; Bengt Herweg; Dany Sayad; Javier Saiz; Sami Noujaim
Journal:  Front Pharmacol       Date:  2019-11-27       Impact factor: 5.810
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.